findmyKOL
Clinical trialNCT06617572AvailableExpanded Access

Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel

SponsorUSWM CT, LLCMyxoid LiposarcomaSynovial Sarcoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this expanded access protocol (EAP) is to provide controlled access to Afamitresgene autoleucel, suspension for intravenous infusion that does not meet the commercial release specification (NC afami-cel). This EAP will be conducted at authorized treatment centers where TECELRA® is being administered and where the EAP is approved to be conducted. Patients who are prescribed TECELRA® , sign the informed consent form, and meet all entry criteria will be eligible to participate in this protocol.
clinicaltrials.gov ↗

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mayo Arizona

    Phoenix, Arizona, United States

    Mahesh Seetharam, MD
    Available
  • Stanford Hospital and Clinics

    Stanford, California, United States

    Kristen Ganjoo, MD
    Available
  • Mayo Florida

    Jacksonville, Florida, United States

    Steven Attia, MD
    Available
  • Moffit Cancer Center

    Tampa, Florida, United States

    Mihaela Druta, MD
    Available
  • Northwestern University Feinberg School of Medicine

    Chicago, Illinois, United States

    Seth Pollack, MD
    Available
  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

    Michael Wagner, MD
    Available
  • Massachusetts General Hospital

    Boston, Massachusetts, United States

    Edwin Choy, MD
    Available
  • Mayo Rochester

    Rochester, Minnesota, United States

    Steven Robinson, MD
    Available
  • Memorial Sloan Kettering Cancer Centre

    New York, New York, United States

    Sandra D Angelo, MD
    Available
  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania, United States

    Henry Fung, MD
    Available
  • Md Anderson Cancer Center

    Houston, Texas, United States

    Dejka Araujo, MD
    Available

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
—
Primary completion
—
Completion
—
Last update posted
11 Aug 2026
Registered enrollment
—
Registry id
NCT06617572
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.